Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer Article Swipe
Satoshi Endo
,
Hisao Imai
,
Atsuto Mouri
,
Kasumi Tsukamoto
,
Kenji Masaki
,
Kosuke Hashimoto
,
Yu Miura
,
Ayako Shiono
,
Ou Yamaguchi
,
Junichi Nakagawa
,
Kyoichi Kaira
,
Kunihiko Kobayashi
,
Hiroshi Kagamu
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1007/s00432-025-06089-x
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1007/s00432-025-06089-x
First-line Nivo-Ipi therapy is effective in elderly patients with NSCLC. Although there was an increased incidence of pneumonitis, the treatment was manageable and presented as a viable treatment option. Notably, the occurrence of treatment-related AEs was associated with improved clinical outcomes, suggesting a potential prognostic value of AEs in this population.
Related Topics
Concepts
Nivolumab
Medicine
Ipilimumab
Hematology
Internal medicine
Oncology
Lung cancer
Cancer
Immunotherapy
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s00432-025-06089-x
- https://link.springer.com/content/pdf/10.1007/s00432-025-06089-x.pdf
- OA Status
- gold
- Cited By
- 2
- References
- 56
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4406711270
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4406711270Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s00432-025-06089-xDigital Object Identifier
- Title
-
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancerWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-01-23Full publication date if available
- Authors
-
Satoshi Endo, Hisao Imai, Atsuto Mouri, Kasumi Tsukamoto, Kenji Masaki, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Junichi Nakagawa, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi KagamuList of authors in order
- Landing page
-
https://doi.org/10.1007/s00432-025-06089-xPublisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1007/s00432-025-06089-x.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1007/s00432-025-06089-x.pdfDirect OA link when available
- Concepts
-
Nivolumab, Medicine, Ipilimumab, Hematology, Internal medicine, Oncology, Lung cancer, Cancer, ImmunotherapyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2Per-year citation counts (last 5 years)
- References (count)
-
56Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4406711270 |
|---|---|
| doi | https://doi.org/10.1007/s00432-025-06089-x |
| ids.doi | https://doi.org/10.1007/s00432-025-06089-x |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39843575 |
| ids.openalex | https://openalex.org/W4406711270 |
| fwci | 6.54107818 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D002289 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[2].qualifier_ui | Q000473 |
| mesh[2].descriptor_ui | D002289 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | pathology |
| mesh[2].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[3].qualifier_ui | Q000401 |
| mesh[3].descriptor_ui | D002289 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | mortality |
| mesh[3].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[4].qualifier_ui | Q000008 |
| mesh[4].descriptor_ui | D000077594 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | administration & dosage |
| mesh[4].descriptor_name | Nivolumab |
| mesh[5].qualifier_ui | Q000009 |
| mesh[5].descriptor_ui | D000077594 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | adverse effects |
| mesh[5].descriptor_name | Nivolumab |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D000368 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Aged |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D008297 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Male |
| mesh[9].qualifier_ui | Q000008 |
| mesh[9].descriptor_ui | D000074324 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | administration & dosage |
| mesh[9].descriptor_name | Ipilimumab |
| mesh[10].qualifier_ui | Q000009 |
| mesh[10].descriptor_ui | D000074324 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | adverse effects |
| mesh[10].descriptor_name | Ipilimumab |
| mesh[11].qualifier_ui | Q000188 |
| mesh[11].descriptor_ui | D008175 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | drug therapy |
| mesh[11].descriptor_name | Lung Neoplasms |
| mesh[12].qualifier_ui | Q000473 |
| mesh[12].descriptor_ui | D008175 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | pathology |
| mesh[12].descriptor_name | Lung Neoplasms |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000369 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Aged, 80 and over |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D012189 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Retrospective Studies |
| mesh[15].qualifier_ui | Q000627 |
| mesh[15].descriptor_ui | D000971 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | therapeutic use |
| mesh[15].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[16].qualifier_ui | Q000009 |
| mesh[16].descriptor_ui | D000971 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | adverse effects |
| mesh[16].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000077982 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Progression-Free Survival |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | Q000188 |
| mesh[19].descriptor_ui | D002289 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | drug therapy |
| mesh[19].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[20].qualifier_ui | Q000473 |
| mesh[20].descriptor_ui | D002289 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | pathology |
| mesh[20].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[21].qualifier_ui | Q000401 |
| mesh[21].descriptor_ui | D002289 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | mortality |
| mesh[21].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[22].qualifier_ui | Q000008 |
| mesh[22].descriptor_ui | D000077594 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | administration & dosage |
| mesh[22].descriptor_name | Nivolumab |
| mesh[23].qualifier_ui | Q000009 |
| mesh[23].descriptor_ui | D000077594 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | adverse effects |
| mesh[23].descriptor_name | Nivolumab |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000368 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Aged |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D005260 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Female |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D008297 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Male |
| mesh[27].qualifier_ui | Q000008 |
| mesh[27].descriptor_ui | D000074324 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | administration & dosage |
| mesh[27].descriptor_name | Ipilimumab |
| mesh[28].qualifier_ui | Q000009 |
| mesh[28].descriptor_ui | D000074324 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | adverse effects |
| mesh[28].descriptor_name | Ipilimumab |
| mesh[29].qualifier_ui | Q000188 |
| mesh[29].descriptor_ui | D008175 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | drug therapy |
| mesh[29].descriptor_name | Lung Neoplasms |
| mesh[30].qualifier_ui | Q000473 |
| mesh[30].descriptor_ui | D008175 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | pathology |
| mesh[30].descriptor_name | Lung Neoplasms |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000369 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Aged, 80 and over |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D012189 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Retrospective Studies |
| mesh[33].qualifier_ui | Q000627 |
| mesh[33].descriptor_ui | D000971 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | therapeutic use |
| mesh[33].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[34].qualifier_ui | Q000009 |
| mesh[34].descriptor_ui | D000971 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | adverse effects |
| mesh[34].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000077982 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Progression-Free Survival |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D006801 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Humans |
| mesh[37].qualifier_ui | Q000188 |
| mesh[37].descriptor_ui | D002289 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | drug therapy |
| mesh[37].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[38].qualifier_ui | Q000473 |
| mesh[38].descriptor_ui | D002289 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | pathology |
| mesh[38].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[39].qualifier_ui | Q000401 |
| mesh[39].descriptor_ui | D002289 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | mortality |
| mesh[39].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[40].qualifier_ui | Q000008 |
| mesh[40].descriptor_ui | D000077594 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | administration & dosage |
| mesh[40].descriptor_name | Nivolumab |
| mesh[41].qualifier_ui | Q000009 |
| mesh[41].descriptor_ui | D000077594 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | adverse effects |
| mesh[41].descriptor_name | Nivolumab |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D000368 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Aged |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D005260 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Female |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D008297 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Male |
| mesh[45].qualifier_ui | Q000008 |
| mesh[45].descriptor_ui | D000074324 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | administration & dosage |
| mesh[45].descriptor_name | Ipilimumab |
| mesh[46].qualifier_ui | Q000009 |
| mesh[46].descriptor_ui | D000074324 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | adverse effects |
| mesh[46].descriptor_name | Ipilimumab |
| mesh[47].qualifier_ui | Q000188 |
| mesh[47].descriptor_ui | D008175 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | drug therapy |
| mesh[47].descriptor_name | Lung Neoplasms |
| mesh[48].qualifier_ui | Q000473 |
| mesh[48].descriptor_ui | D008175 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | pathology |
| mesh[48].descriptor_name | Lung Neoplasms |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D000369 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Aged, 80 and over |
| type | article |
| title | Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer |
| biblio.issue | 1 |
| biblio.volume | 151 |
| biblio.last_page | 43 |
| biblio.first_page | 43 |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T10417 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9994999766349792 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Lung Cancer Treatments and Mutations |
| topics[2].id | https://openalex.org/T10202 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9975000023841858 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Lung Cancer Diagnosis and Treatment |
| is_xpac | False |
| apc_list.value | 3190 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4190 |
| apc_paid.value | 3190 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4190 |
| concepts[0].id | https://openalex.org/C2780030458 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9223440885543823 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7041828 |
| concepts[0].display_name | Nivolumab |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8160722255706787 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2781433595 |
| concepts[2].level | 4 |
| concepts[2].score | 0.786839485168457 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2459042 |
| concepts[2].display_name | Ipilimumab |
| concepts[3].id | https://openalex.org/C194409129 |
| concepts[3].level | 2 |
| concepts[3].score | 0.7672029137611389 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q103824 |
| concepts[3].display_name | Hematology |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.7086644172668457 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.6575826406478882 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C2776256026 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5312162637710571 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q47912 |
| concepts[6].display_name | Lung cancer |
| concepts[7].id | https://openalex.org/C121608353 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4649326503276825 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[7].display_name | Cancer |
| concepts[8].id | https://openalex.org/C2777701055 |
| concepts[8].level | 3 |
| concepts[8].score | 0.20182999968528748 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[8].display_name | Immunotherapy |
| keywords[0].id | https://openalex.org/keywords/nivolumab |
| keywords[0].score | 0.9223440885543823 |
| keywords[0].display_name | Nivolumab |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8160722255706787 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/ipilimumab |
| keywords[2].score | 0.786839485168457 |
| keywords[2].display_name | Ipilimumab |
| keywords[3].id | https://openalex.org/keywords/hematology |
| keywords[3].score | 0.7672029137611389 |
| keywords[3].display_name | Hematology |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.7086644172668457 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.6575826406478882 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/lung-cancer |
| keywords[6].score | 0.5312162637710571 |
| keywords[6].display_name | Lung cancer |
| keywords[7].id | https://openalex.org/keywords/cancer |
| keywords[7].score | 0.4649326503276825 |
| keywords[7].display_name | Cancer |
| keywords[8].id | https://openalex.org/keywords/immunotherapy |
| keywords[8].score | 0.20182999968528748 |
| keywords[8].display_name | Immunotherapy |
| language | en |
| locations[0].id | doi:10.1007/s00432-025-06089-x |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S10075937 |
| locations[0].source.issn | 0171-5216, 1432-1335 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0171-5216 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of Cancer Research and Clinical Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1007/s00432-025-06089-x.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Cancer Research and Clinical Oncology |
| locations[0].landing_page_url | https://doi.org/10.1007/s00432-025-06089-x |
| locations[1].id | pmid:39843575 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of cancer research and clinical oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39843575 |
| locations[2].id | pmh:oai:doaj.org/article:f7bc7fcf21d84df6988693fe3e7e0492 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Journal of Cancer Research and Clinical Oncology, Vol 151, Iss 1, Pp 1-12 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/f7bc7fcf21d84df6988693fe3e7e0492 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11754340 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | J Cancer Res Clin Oncol |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11754340 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5070379525 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8477-5553 |
| authorships[0].author.display_name | Satoshi Endo |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210164148 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Ota, Gunma, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I4210164148 |
| authorships[0].institutions[0].ror | https://ror.org/054z08865 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210164148 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Hyogo Prefectural Cancer Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Satoshi Endo |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Ota, Gunma, Japan |
| authorships[1].author.id | https://openalex.org/A5035023922 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3097-4255 |
| authorships[1].author.display_name | Hisao Imai |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210164148 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Ota, Gunma, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I4210164148 |
| authorships[1].institutions[0].ror | https://ror.org/054z08865 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210164148 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Hyogo Prefectural Cancer Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Hisao Imai |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Ota, Gunma, Japan |
| authorships[2].author.id | https://openalex.org/A5076550697 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8704-8151 |
| authorships[2].author.display_name | Atsuto Mouri |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I8588240 |
| authorships[2].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Saitama Medical University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Atsuto Mouri |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[3].author.id | https://openalex.org/A5018769615 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Kasumi Tsukamoto |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210137409, https://openalex.org/I4210153678 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Respiratory Medicine, National Hospital Organization Disaster Medical Center, Tachikawa , Tokyo, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I4210153678 |
| authorships[3].institutions[0].ror | https://ror.org/056qqqn18 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210137409, https://openalex.org/I4210153678 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | National Disaster Medical Center |
| authorships[3].institutions[1].id | https://openalex.org/I4210137409 |
| authorships[3].institutions[1].ror | https://ror.org/03ntccx93 |
| authorships[3].institutions[1].type | government |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210137409 |
| authorships[3].institutions[1].country_code | JP |
| authorships[3].institutions[1].display_name | National Hospital Organization |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kasumi Tsukamoto |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Division of Respiratory Medicine, National Hospital Organization Disaster Medical Center, Tachikawa , Tokyo, Japan |
| authorships[4].author.id | https://openalex.org/A5050263317 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Kenji Masaki |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I8588240 |
| authorships[4].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Saitama Medical University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kenji Masaki |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[5].author.id | https://openalex.org/A5070064742 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-7627-7901 |
| authorships[5].author.display_name | Kosuke Hashimoto |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[5].institutions[0].id | https://openalex.org/I8588240 |
| authorships[5].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Saitama Medical University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Kosuke Hashimoto |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[6].author.id | https://openalex.org/A5078969338 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-2752-5873 |
| authorships[6].author.display_name | Yu Miura |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[6].institutions[0].id | https://openalex.org/I8588240 |
| authorships[6].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Saitama Medical University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Yu Miura |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[7].author.id | https://openalex.org/A5018407349 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-6546-3864 |
| authorships[7].author.display_name | Ayako Shiono |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[7].institutions[0].id | https://openalex.org/I8588240 |
| authorships[7].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | Saitama Medical University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ayako Shiono |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[8].author.id | https://openalex.org/A5039962714 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7194-6459 |
| authorships[8].author.display_name | Ou Yamaguchi |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[8].institutions[0].id | https://openalex.org/I8588240 |
| authorships[8].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Saitama Medical University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ou Yamaguchi |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[9].author.id | https://openalex.org/A5063484189 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2340-2267 |
| authorships[9].author.display_name | Junichi Nakagawa |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210112046 |
| authorships[9].affiliations[0].raw_affiliation_string | Division of Respiratory Medicine, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan |
| authorships[9].institutions[0].id | https://openalex.org/I4210112046 |
| authorships[9].institutions[0].ror | https://ror.org/02tbkt967 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210112046, https://openalex.org/I4210137409 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | National Hospital Organization Takasaki Medical Center |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Junichi Nakagawa |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Division of Respiratory Medicine, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan |
| authorships[10].author.id | https://openalex.org/A5033780369 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-5548-7686 |
| authorships[10].author.display_name | Kyoichi Kaira |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210112046 |
| authorships[10].affiliations[0].raw_affiliation_string | Division of Respiratory Medicine, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I8588240 |
| authorships[10].affiliations[1].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[10].institutions[0].id | https://openalex.org/I4210112046 |
| authorships[10].institutions[0].ror | https://ror.org/02tbkt967 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210112046, https://openalex.org/I4210137409 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | National Hospital Organization Takasaki Medical Center |
| authorships[10].institutions[1].id | https://openalex.org/I8588240 |
| authorships[10].institutions[1].ror | https://ror.org/04zb31v77 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I8588240 |
| authorships[10].institutions[1].country_code | JP |
| authorships[10].institutions[1].display_name | Saitama Medical University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Kyoichi Kaira |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan, Division of Respiratory Medicine, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan |
| authorships[11].author.id | https://openalex.org/A5029655825 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-6468-9068 |
| authorships[11].author.display_name | Kunihiko Kobayashi |
| authorships[11].countries | JP |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[11].institutions[0].id | https://openalex.org/I8588240 |
| authorships[11].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[11].institutions[0].country_code | JP |
| authorships[11].institutions[0].display_name | Saitama Medical University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Kunihiko Kobayashi |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[12].author.id | https://openalex.org/A5007350359 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-4523-8517 |
| authorships[12].author.display_name | Hiroshi Kagamu |
| authorships[12].countries | JP |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| authorships[12].institutions[0].id | https://openalex.org/I8588240 |
| authorships[12].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[12].institutions[0].country_code | JP |
| authorships[12].institutions[0].display_name | Saitama Medical University |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Hiroshi Kagamu |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1007/s00432-025-06089-x.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W4313890856, https://openalex.org/W3043703771, https://openalex.org/W2766929851, https://openalex.org/W3210130056, https://openalex.org/W4393305029, https://openalex.org/W4236421112, https://openalex.org/W2973740076, https://openalex.org/W4241093956, https://openalex.org/W2899127460, https://openalex.org/W2947988614 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1007/s00432-025-06089-x |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S10075937 |
| best_oa_location.source.issn | 0171-5216, 1432-1335 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0171-5216 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of Cancer Research and Clinical Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s00432-025-06089-x.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Cancer Research and Clinical Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s00432-025-06089-x |
| primary_location.id | doi:10.1007/s00432-025-06089-x |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S10075937 |
| primary_location.source.issn | 0171-5216, 1432-1335 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0171-5216 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of Cancer Research and Clinical Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s00432-025-06089-x.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Cancer Research and Clinical Oncology |
| primary_location.landing_page_url | https://doi.org/10.1007/s00432-025-06089-x |
| publication_date | 2025-01-23 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3001449972, https://openalex.org/W2990652289, https://openalex.org/W3107453141, https://openalex.org/W4386337424, https://openalex.org/W4385798580, https://openalex.org/W2010121426, https://openalex.org/W4304807333, https://openalex.org/W2289841322, https://openalex.org/W3023823544, https://openalex.org/W1849671624, https://openalex.org/W2151986118, https://openalex.org/W4210696432, https://openalex.org/W4226136872, https://openalex.org/W4400060459, https://openalex.org/W2019607817, https://openalex.org/W2110847259, https://openalex.org/W2228221433, https://openalex.org/W2759963646, https://openalex.org/W2976744492, https://openalex.org/W3107738233, https://openalex.org/W2996119364, https://openalex.org/W4210370153, https://openalex.org/W3216993465, https://openalex.org/W2151522757, https://openalex.org/W4403912573, https://openalex.org/W2915478882, https://openalex.org/W3196861824, https://openalex.org/W3137983544, https://openalex.org/W2962053530, https://openalex.org/W3012136773, https://openalex.org/W2521786544, https://openalex.org/W4293724290, https://openalex.org/W4210792133, https://openalex.org/W2735521483, https://openalex.org/W2121095198, https://openalex.org/W2106511606, https://openalex.org/W2511043440, https://openalex.org/W2024360503, https://openalex.org/W2058408106, https://openalex.org/W2999263395, https://openalex.org/W2137053633, https://openalex.org/W3185428150, https://openalex.org/W3128646645, https://openalex.org/W2160834915, https://openalex.org/W4392546693, https://openalex.org/W2099609050, https://openalex.org/W3215873179, https://openalex.org/W4396941715, https://openalex.org/W2887577080, https://openalex.org/W3217126890, https://openalex.org/W4226258201, https://openalex.org/W4213046685, https://openalex.org/W3017217098, https://openalex.org/W4210753337, https://openalex.org/W2560367415, https://openalex.org/W2572174216 |
| referenced_works_count | 56 |
| abstract_inverted_index.a | 25, 42 |
| abstract_inverted_index.an | 13 |
| abstract_inverted_index.as | 24 |
| abstract_inverted_index.in | 5, 48 |
| abstract_inverted_index.is | 3 |
| abstract_inverted_index.of | 16, 32, 46 |
| abstract_inverted_index.AEs | 34, 47 |
| abstract_inverted_index.and | 22 |
| abstract_inverted_index.the | 18, 30 |
| abstract_inverted_index.was | 12, 20, 35 |
| abstract_inverted_index.this | 49 |
| abstract_inverted_index.with | 8, 37 |
| abstract_inverted_index.there | 11 |
| abstract_inverted_index.value | 45 |
| abstract_inverted_index.NSCLC. | 9 |
| abstract_inverted_index.viable | 26 |
| abstract_inverted_index.elderly | 6 |
| abstract_inverted_index.option. | 28 |
| abstract_inverted_index.therapy | 2 |
| abstract_inverted_index.Although | 10 |
| abstract_inverted_index.Nivo-Ipi | 1 |
| abstract_inverted_index.Notably, | 29 |
| abstract_inverted_index.clinical | 39 |
| abstract_inverted_index.improved | 38 |
| abstract_inverted_index.patients | 7 |
| abstract_inverted_index.effective | 4 |
| abstract_inverted_index.incidence | 15 |
| abstract_inverted_index.increased | 14 |
| abstract_inverted_index.outcomes, | 40 |
| abstract_inverted_index.potential | 43 |
| abstract_inverted_index.presented | 23 |
| abstract_inverted_index.treatment | 19, 27 |
| abstract_inverted_index.First-line | 0 |
| abstract_inverted_index.associated | 36 |
| abstract_inverted_index.manageable | 21 |
| abstract_inverted_index.occurrence | 31 |
| abstract_inverted_index.prognostic | 44 |
| abstract_inverted_index.suggesting | 41 |
| abstract_inverted_index.population. | 50 |
| abstract_inverted_index.pneumonitis, | 17 |
| abstract_inverted_index.treatment-related | 33 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 95 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 13 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6800000071525574 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.90037762 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |